Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linagliptin for Myocardial Diastolic Function in T2DM
NCT01888796Phase 3Terminated
- Sponsor
- RWTH Aachen University
- Start
- Sep 2013
- Primary completion
- Dec 2014
- Countries
- 1
01
Overview
A Phase 3 trial of linagliptin in type 2 diabetes mellitus (T2DM), left ventricular diastolic dysfunction (LVDD), sponsored by RWTH Aachen University. Started Sep 2013; status: terminated.
02
Drugs
linagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)left ventricular diastolic dysfunction (LVDD)
Beyond the preview
Go deeper on NCT01888796.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01888796.